Pfenex Inc. SEC Filings

Filed On	Filing
11 Feb 2021	SC 13G/A
09 Dec 2020	SC 13G/A
09 Oct 2020	SC 13G/A
09 Oct 2020	SC 13G/A
09 Oct 2020	SC 13G/A
09 Oct 2020	SC 13G/A
09 Oct 2020	Form 3: Ligand Pharmaceuticals Inc, 10% owner Holds 27,034,437 shares of Common Stock
05 Oct 2020	Form 4: Schneider Phillip M, Director Disposed of 11,000 shares (Tender Offer) · Disposed of 110,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Lucy Patrick K., Chief Business Officer Disposed of 90,246 shares (Tender Offer) · Disposed of 372,865 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Marquet Magda, Director Disposed of 43,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Scranton Shawn, Chief Operating Officer Disposed of 155,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Campbell Robin, Director Disposed of 5,000 shares (Tender Offer) · Disposed of 110,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Brenner Martin, Chief Scientific Officer Disposed of 123,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Masuoka Lorianne, Director Disposed of 43,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Grenfell-Gardner Jason, Director Disposed of 10,000 shares (Tender Offer) · Disposed of 79,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Schimmelpennink Evert B., Director Disposed of 26,658 shares (Tender Offer) · Disposed of 1,070,062 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	Form 4: Taylor John Mack, Director Disposed of 115,000 Stock Option (right to buy) (Tender Offer)
05 Oct 2020	15-12B
05 Oct 2020	SC 13D/A
02 Oct 2020	EFFECT

Comments